Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 17/07/2024 BST			5-day change	1st Jan Change
133.5 ^USD	-1.88%		+5.06%	-3.98%

07-10	Citigroup Upgrades Agilent Technologies to Buy From Neutral, Adjusts Price Target to $150 From $135	MT
07-02	Evercore ISI Raises Price Target on Agilent Technologies to $130 From $126, Maintains In Line Rating	MT

Agilent Technologies, Inc. (NYSE : A) acquired Avida Biomed Inc for $30 million.

January 03, 2023

Agilent Technologies, Inc. (NYSE : A) acquired Avida Biomed Inc. for $30 million on January 4, 2023.

Agilent Technologies, Inc. (NYSE : A) completed the acquisition of Avida Biomed Inc. on January 4, 2023.

Latest news about Agilent Technologies, Inc.

Citigroup Upgrades Agilent Technologies to Buy From Neutral, Adjusts Price Target to $150 From $135	07-10	MT
Evercore ISI Raises Price Target on Agilent Technologies to $130 From $126, Maintains In Line Rating	07-02	MT
Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary	07-01	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell Midcap Growth Index	06-30	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 3000 Growth Index	06-30	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 3000E Growth Index	06-30	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth Index	06-30	CI
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth-Defensive Index	06-30	CI
Wolfe Research Downgrades Agilent Technologies to Peer Perform From Outperform	06-27	MT
RareCyte, Inc. announced that it has received $20 million in funding from a group of investors	06-26	CI
Masimo Shareholder Politan Capital Campaigns for 2 More Board Seats	06-26	MT
Bristol Myers: ex-CEO of Agilent joins Board of Directors	06-19	CF
MGI Tech Co., Ltd. and SeqOne Partner to Advance End-To-End Genomic Analysis	06-17	CI
Agilent Technologies Insider Sold Shares Worth $1,999,262, According to a Recent SEC Filing	06-12	MT
Agilent Technologies Insider Sold Shares Worth $254,540, According to a Recent SEC Filing	06-05	MT
Agilent Technologies Seeks M&A	06-05	CI
Transcript : Agilent Technologies, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 08:30 AM	06-05
Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics	06-03	CI
Tranche Update on Agilent Technologies, Inc. (NYSE:A)'s Equity Buyback Plan announced on January 9, 2023.	06-03	CI
A new phase for the market	05-30
UBS Cuts Price Target on Agilent Technologies to $141 From $155, Keeps Neutral Rating	05-30	MT
Wolfe Research Adjusts Agilent Technologies' PT to $135 From $155	05-30	MT
Leerink Adjusts Price Target on Agilent Technologies to $135 From $150	05-30	MT
Stifel Adjusts Price Target on Agilent Technologies to $151 From $163	05-30	MT
JPMorgan Adjusts Price Target on Agilent Technologies to $155 From $165	05-30	MT

Chart Agilent Technologies, Inc.

Duration

Period

More charts

Company Profile

Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (73.9%) and services (26.1%). Net sales are distributed geographically as follows: the United States (40%), China (34.3%) and other (25.7%).

Sector

Advanced Medical Equipment & Technology

Calendar

21/08/2024 - Q3 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Agilent Technologies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

133.5 USD

Average target price

141 USD

Spread / Average Target

+5.64%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
AGILENT TECHNOLOGIES, INC.	-3.98%	39.7B
THERMO FISHER SCIENTIFIC	+4.57%	212B
DANAHER CORPORATION	+8.61%	187B
INTUITIVE SURGICAL, INC.	+26.34%	155B
BOSTON SCIENTIFIC CORPORATION	+33.90%	115B
SIEMENS HEALTHINEERS AG	+2.17%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+14.50%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	45.25B
GE HEALTHCARE TECHNOLOGIES INC.	+6.66%	37.72B
RESMED, INC.	+19.72%	30.38B

Other Advanced Medical Equipment & Technology